Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

For better result, minimum character length is four(4)
Results 121 - 130 of 229 for CRO. (0.06 seconds)

Outstrips Broad Market. More details...
Positive News for Johnson & Johnson. More details...
Holiday Doldrums Set In During the Afternoon. More...
CBT 200 Bounces 5.8% Off Lows. More details...
Individual Issues Shine Despite General Decline. More...
One Death, One Rare CNS Disease Cause Recall. More...
CBT 200 Loses Calamitous 4.26%. More details...
What Are the Company's Prospects Following Recall?. More...
Patient Was Not Taking Avonex. More details...
Broad Market Pulls Off Small Gain. More details...
prev | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | next
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital